Clinical Trial

Plasma Calcitonin Gene-Related Peptide (CGRP) Levels in Patients With Head and Neck Malignancies Undergoing Radiotherapy

Completed
View on ClinicalTrials.gov →
Summary
This prospective study investigates the dynamic changes in plasma calcitonin gene-related peptide (CGRP) levels during radiotherapy and their association with radiotherapy-related pain in patients with head and neck malignancies.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-11; most recent amendment 2026-04-20.
Status change: Recruiting → Completed 2026-04-20
Status change: Not Yet Recruiting → Recruiting 2025-07-09
Trial Details
NCT Number NCT07029373
Lead Sponsor West China Hospital
Conditions Head and Neck Cancer
Enrollment 23 participants
Start Date 2025-07-04
Primary Completion 2026-04-02 (estimated)
Study Completion 2026-04-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-21